News
12-14-2013, 08:30 AM
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
More... (http://www.news-medical.net/news/20131214/Bisphosphonate-zoledronate-treatment-not-effective-in-women-with-chemoresistant-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20131214/Bisphosphonate-zoledronate-treatment-not-effective-in-women-with-chemoresistant-breast-cancer.aspx)